ArticleNeoplasia (New York, N.Y.)2026

Hypoxia-activated PROTAC for dual inhibition of FAK and EGFR enables synergistic mechano-chemical cancer therapy.

Keli An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.